{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T18:03:08Z","timestamp":1770746588965,"version":"3.49.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004366","name":"Tabriz University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004366","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.jpba.2024.116223","type":"journal-article","created":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T06:28:14Z","timestamp":1715754494000},"page":"116223","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Quantification of Arbutin and its degradation products, hydroquinone and p-Benzoquinone, in hyperpigmentation topical formulation: Effect of extraction procedure and interference assessment"],"prefix":"10.1016","volume":"246","author":[{"given":"Yousef","family":"Khadivi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Midia","family":"Saeedpour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiva","family":"Arjmandmazidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahboob","family":"Nemati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farnaz","family":"Monajjemzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2024.116223_bib1","doi-asserted-by":"crossref","DOI":"10.7759\/cureus.48840","article-title":"Topical HYdroquinone for Hyperpigmentation: A Narrative Review","author":"Fabian","year":"2023","journal-title":"Cureus 15(11"},{"issue":"6","key":"10.1016\/j.jpba.2024.116223_bib2","doi-asserted-by":"crossref","DOI":"10.1111\/dth.14095","article-title":"The top 10 cosmeceuticals for facial hyperpigmentation","volume":"33","author":"Searle","year":"2020","journal-title":"Dermatol. Ther."},{"issue":"46","key":"10.1016\/j.jpba.2024.116223_bib3","doi-asserted-by":"crossref","first-page":"4784","DOI":"10.1039\/D2AY01631A","article-title":"Determination of hydroquinone and benzoquinone in pharmaceutical formulations: critical considerations on quantitative analysis of easily oxidized compounds","volume":"14","author":"Brito de Oliveira Moreira","year":"2022","journal-title":"Anal. Methods"},{"issue":"4","key":"10.1016\/j.jpba.2024.116223_bib4","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1080\/09546634.2021.1940811","article-title":"Emerging topical therapies to treat pigmentary disorders: an evidence-based approach","volume":"33","author":"Hu","year":"2022","journal-title":"J. Dermatol. Treat."},{"key":"10.1016\/j.jpba.2024.116223_bib5","unstructured":"E. EC, Regulation (EC) No. 1223\/2009 of the European Parliament and of the Council of 30 November 2009 on cosmetic products (recast), Off J Eur Union \u3008http:\/\/eur-lex.europa.eu\/LexUriServ\/LexUriServ.do\u3009 (2009)."},{"key":"10.1016\/j.jpba.2024.116223_bib6","unstructured":"C.I. Hotlist, Prohibited and Restricted Ingredients, Available at: Health Canada Website: \u3008http:\/\/www.hc-sc.gc.ca\/cpsspc\/cosmet-person\/hot-list-critique\/hotlist-liste-eng.php\u3009 (2020)."},{"issue":"7","key":"10.1016\/j.jpba.2024.116223_bib7","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.3390\/antiox10071129","article-title":"Arbutin as a skin depigmenting agent with antimelanogenic and antioxidant properties","volume":"10","author":"Boo","year":"2021","journal-title":"Antioxid. (Basel)"},{"issue":"15","key":"10.1016\/j.jpba.2024.116223_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27154774","article-title":"Timeline of the development of skin-lightening active ingredients in Japan","volume":"27","author":"Maeda","year":"2022","journal-title":"Molecules"},{"issue":"6","key":"10.1016\/j.jpba.2024.116223_bib9","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1002\/pca.2953","article-title":"Comparative stability of arbutin in Arctostaphylos uva-ursi by a new comprehensive stability-indicating HPLC method","volume":"31","author":"Braga","year":"2020","journal-title":"Phytochem Anal."},{"issue":"5","key":"10.1016\/j.jpba.2024.116223_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18050969","article-title":"Study of Hydroquinone Mediated Cytotoxicity and Hypopigmentation Effects from UVB-Irradiated Arbutin and DeoxyArbutin","volume":"18","author":"Chang","year":"2017","journal-title":"Int J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.jpba.2024.116223_bib11","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1473-2165.2008.00387.x","article-title":"Hydrolysis of arbutin to hydroquinone by human skin bacteria and its effect on antioxidant activity","volume":"7","author":"Bang","year":"2008","journal-title":"J. Cosmet. Dermatol."},{"key":"10.1016\/j.jpba.2024.116223_bib12","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.tox.2015.11.002","article-title":"Reactivity measurement in estimation of benzoquinone and benzoquinone derivatives' allergenicity","volume":"339","author":"Mbiya","year":"2016","journal-title":"Toxicology"},{"key":"10.1016\/j.jpba.2024.116223_bib13","unstructured":"N.J.D.o.H.a.S. Services, p-BENZOQUINONE in: D.o. Health (Ed.) The State of New Jersey, 2004."},{"key":"10.1016\/j.jpba.2024.116223_bib14","first-page":"1","article-title":"The Effect of Azelaic Acid and Vitamin C on the Stability of Hydroquinone in Extemporaneous Topical Preparations: an Evidence-Based In Vitro Research","author":"Azimi","year":"2022","journal-title":"J. Pharm. Innov."},{"key":"10.1016\/j.jpba.2024.116223_bib15","article-title":"USP 40\u2013NF 35, Assessment of drug product performance-bioavailability","volume":"1090","author":"Pharmacopeia","year":"2017","journal-title":"Bioequivalence, Dissolution"},{"key":"10.1016\/j.jpba.2024.116223_bib16","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jpba.2013.04.020","article-title":"Development and validation of a fast chromatographic method for screening and quantification of legal and illegal skin whitening agents","volume":"83","author":"Desmedt","year":"2013","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"5","key":"10.1016\/j.jpba.2024.116223_bib17","doi-asserted-by":"crossref","first-page":"530","DOI":"10.4103\/0250-474X.169031","article-title":"New High-performance Liquid Chromatography-DAD Method for Analytical Determination of Arbutin and Hydroquinone in Rat Plasma","volume":"77","author":"Gallo","year":"2015","journal-title":"Indian J. Pharm. Sci."},{"issue":"1","key":"10.1016\/j.jpba.2024.116223_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jfda.2019.10.002","article-title":"Simultaneous determination of magnesium ascorbyl phosphate, ascorbyl glucoside, kojic acid, arbutin and hydroquinone in skin whitening cosmetics by HPLC","volume":"12","author":"Huang","year":"2004","journal-title":"J. Food Drug Anal."},{"issue":"6","key":"10.1016\/j.jpba.2024.116223_bib19","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/ics.12228","article-title":"Simultaneous determination of arbutin and its decomposed product hydroquinone in whitening creams using high-performance liquid chromatography with photodiode array detection: Effect of temperature and pH on decomposition","volume":"37","author":"Jeon","year":"2015","journal-title":"Int J. Cosmet. Sci."},{"issue":"3","key":"10.1016\/j.jpba.2024.116223_bib20","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/ics.12292","article-title":"Simultaneous determination of water-soluble whitening ingredients and adenosine in different cosmetic formulations by high-performance liquid chromatography coupled with photodiode array detection","volume":"38","author":"Jeon","year":"2016","journal-title":"Int J. Cosmet. Sci."},{"key":"10.1016\/j.jpba.2024.116223_bib21","series-title":"SCCS OPINION on the safety of alpha-arbutin and beta-arbutin in cosmetic products-SCCS\/1642\/22\u2013Final Opinion","author":"Bernauer","year":"2023"},{"issue":"20","key":"10.1016\/j.jpba.2024.116223_bib22","first-page":"05","article-title":"Validation of analytical procedures: text and methodology","volume":"1","author":"Guideline","year":"2005","journal-title":"Q2 (R1)"},{"key":"10.1016\/j.jpba.2024.116223_bib23","unstructured":"consultglp, A linear regression approach to check bias between methods \u2013 Part IA linear regression approach to check bias between methods \u2013 Part I. \u3008https:\/\/consultglp.com\/2018\/02\/25\/a-linear-regression-approach-to-check-bias-between-methods-part-i\/\u3009, 2018)."},{"key":"10.1016\/j.jpba.2024.116223_bib24","first-page":"1190","article-title":"Validation of analytical methods in a pharmaceutical quality system: An overview focused on HPLC methods","volume":"43","author":"Marson","year":"2020","journal-title":"Qu\u00edmica Nova"},{"key":"10.1016\/j.jpba.2024.116223_bib25","series-title":"Aulton's Pharmaceutics E-Book: Aulton's Pharmaceutics E-Book","author":"Taylor","year":"2021"},{"key":"10.1016\/j.jpba.2024.116223_bib26","series-title":"Chemical kinetics: the study of reaction rates in solution","author":"Connors","year":"1990"}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708524002632?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708524002632?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T02:55:23Z","timestamp":1740797723000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708524002632"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":26,"alternative-id":["S0731708524002632"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2024.116223","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quantification of Arbutin and its degradation products, hydroquinone and p-Benzoquinone, in hyperpigmentation topical formulation: Effect of extraction procedure and interference assessment","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2024.116223","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116223"}}